ICD 10 D31.2 describes a medical condition characterized by the presence of a benign neoplasm, or noncancerous mass, of abnormal cells in the retina, which is the layer of tissue at the back of the eye responsible for sensing light and transmitting images to the brain, and this type of neoplasm lacks the ability to spread to nearby tissues, or metastasize, and risk factors for developing this condition include advanced age, a history of spots or moles in the eyes, exposure to ultraviolet (UV) light, and genetic predisposition.
Official Description Of D31.2
The ICD 10 CM book defines ICD 10 code D31.2 as:
hemangioma of retina (D49.81)
neoplasm of unspecified behavior of retina and choroid (D49.81)
retinal freckle (D49.81)
Excludes1: benign neoplasm of connective tissue of eyelid (D21.0)
benign neoplasm of optic nerve (D33.3)
benign neoplasm of skin of eyelid (D22.1-, D23.1-)
The diagnosis described by ICD 10 CM code D31.2 pertains to a type of eye condition known as a benign neoplasm of the retina. This condition is considered to be non-cancerous and generally does not pose severe health risks to the patient. However, it can still cause a range of symptoms that may affect an individual’s vision and overall quality of life.
The symptoms associated with a benign neoplasm of the retina can include an abnormal white reflection in the eye, as well as a yellowish or whitish mass that may emerge in the eye accompanied by discomfort, such as pain or blurred vision. Some individuals may experience a loss of peripheral vision or sensitivity to light, while others may see flashes of light, floaters, or red or light-colored spots due to deposits in the vitreous of the eye.
When a patient presents with these symptoms, the provider will typically perform a thorough physical examination and review of the patient’s medical history. Diagnostic tests are also commonly used to confirm the diagnosis of a benign neoplasm of the retina. Among the diagnostic tests used are ocular lesion biopsies, ultrasound imaging of the eye, fluorescein angiography, CT scans, MRI scans, and PET scans. These diagnostic tests can help the provider determine the extent and severity of the condition and plan appropriate treatment.
Treatment for a benign neoplasm of the retina is generally only necessary when the tumor begins to cause discomfort or to grow in size. The primary treatment for this type of tumor is surgical removal. However, alternative therapies such as cryotherapy and laser therapy may also be performed in some cases.
The prognosis for individuals diagnosed with a benign neoplasm of the retina depends on the severity of the condition. In general, the outlook is positive, and most individuals with this condition will be able to enjoy a relatively normal life with few if any, significant health problems.
In summary, ICD 10 CM D31.2 is used to describe a benign neoplasm of the retina, which may cause a range of symptoms, such as blurred vision, pain, and sensitivity to light. Diagnostic tests such as ultrasound and biopsy are typically used to confirm the diagnosis, while surgical removal is typically the primary treatment option. Prognosis is generally good, and most individuals can expect to live a normal life after treatment.